Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxia.
Journal
Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
revised:
16
02
2023
received:
23
12
2022
accepted:
26
05
2023
medline:
15
8
2023
pubmed:
19
6
2023
entrez:
19
6
2023
Statut:
ppublish
Résumé
Friedreich ataxia (FRDA) is an inherited condition caused by a GAA triplet repeat (GAA-TR) expansion in the FXN gene. Clinical features of FRDA include ataxia, cardiomyopathy, and in some, vision loss. In this study, we characterize features of vision loss in a large cohort of adults and children with FRDA. Using optical coherence tomography (OCT), we measured peripapillary retinal nerve fiber layer (RNFL) thickness in 198 people with FRDA, and 77 controls. Sloan letter charts were used to determine visual acuity. RNFL thickness and visual acuity were compared to measures of disease severity obtained from the Friedreich Ataxia Clinical Outcomes Measures Study (FACOMS). The majority of patients, including children, had pathologically thin RNFLs (mean = 73 ± 13 μm in FRDA; 98 ± 9 μm in controls) and low-contrast vision deficits early in the disease course. Variability in RNFL thickness in FRDA (range: 36 to 107 μm) was best predicted by disease burden (GAA-TR length X disease duration). Significant deficits in high-contrast visual acuity were apparent in patients with an RNFL thickness of ≤68 μm. RNFL thickness decreased at a rate of -1.2 ± 1.4 μm/year and reached 68 μm at a disease burden of approximately 12,000 GAA years, equivalent to disease duration of 17 years for participants with 700 GAAs. These data suggest that both hypoplasia and subsequent degeneration of the RNFL may be responsible for the optic nerve dysfunction in FRDA and support the development of a vision-directed treatment for selected patients early in the disease to prevent RNFL loss from reaching the critical threshold.
Identifiants
pubmed: 37334854
doi: 10.1002/acn3.51830
pmc: PMC10424660
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1397-1406Informations de copyright
© 2023 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Références
J Child Neurol. 2012 Sep;27(9):1152-8
pubmed: 22752494
J Neurol. 2013 Sep;260(9):2362-9
pubmed: 23775342
Ann Clin Transl Neurol. 2020 Jan;7(1):94-104
pubmed: 31854120
J Neuroophthalmol. 2020 Jun;40(2):213-217
pubmed: 31977662
J Neuropathol Exp Neurol. 2017 Nov 1;76(11):969-977
pubmed: 29044418
Science. 1996 Mar 8;271(5254):1423-7
pubmed: 8596916
Neurol Genet. 2022 May 17;8(3):e683
pubmed: 35620135
Brain. 2009 Jan;132(Pt 1):116-23
pubmed: 18931386
Am J Ophthalmol. 2017 Sep;181:106-113
pubmed: 28669780
Mov Disord. 2023 Jun;38(6):970-977
pubmed: 36928898
Ann Neurol. 2021 Oct;90(4):570-583
pubmed: 34435700
Handb Clin Neurol. 2012;103:275-94
pubmed: 21827895
J Neuroophthalmol. 2014 Jun;34(2):118-21
pubmed: 24275983
Eur J Neurol. 2019 Mar;26(3):483-489
pubmed: 30326180
J Neurol Neurosurg Psychiatry. 2000 May;68(5):661-4
pubmed: 10766903
Cerebellum. 2013 Feb;12(1):43-7
pubmed: 22562714
J Neurol. 2009 Jul;256(7):1114-20
pubmed: 19280106
Mol Genet Metab. 2007 Sep-Oct;92(1-2):23-35
pubmed: 17596984
Ann Neurol. 2016 Mar;79(3):485-95
pubmed: 26704351
Neurology. 2006 Jun 13;66(11):1711-6
pubmed: 16769945
J Neuroophthalmol. 2002 Dec;22(4):270-4
pubmed: 12464730
Neurol Genet. 2018 Jul 23;4(4):e250
pubmed: 30065952
Ann Clin Transl Neurol. 2022 Dec;9(12):2041-2046
pubmed: 36394163
Ann Neurol. 1999 Feb;45(2):200-6
pubmed: 9989622
Neurogenetics. 2010 May;11(2):261-5
pubmed: 20162437
Mov Disord. 2010 Mar 15;25(4):426-32
pubmed: 20063431
J Neurol. 2020 Feb;267(2):350-358
pubmed: 31641877
Tomography. 2021 Dec 08;7(4):915-931
pubmed: 34941648
N Engl J Med. 1996 Oct 17;335(16):1169-75
pubmed: 8815938
Neurology. 2022 Jul 11;:
pubmed: 35817567
Ophthalmology. 2020 Mar;127(3):357-368
pubmed: 31732228
Neurol Genet. 2019 Oct 29;5(6):371
pubmed: 32042904
Eur Neurol. 1988;28(5):246-51
pubmed: 3224618
Eye (Lond). 2016 Oct;30(10):1378-1380
pubmed: 27419835
J Neurol. 2009 Mar;256 Suppl 1:3-8
pubmed: 19283344
Neurology. 2019 Jul 9;93(2):e116-e124
pubmed: 31197032
Brain. 2019 Jun 1;142(6):e23
pubmed: 31081508
J Neuroophthalmol. 2000 Dec;20(4):229-33
pubmed: 11130744
Hum Gene Ther. 2022 Sep;33(17-18):865-878
pubmed: 36074935
Ann Clin Transl Neurol. 2016 Jul 25;3(9):684-94
pubmed: 27648458